ReShape Lifesciences IncNASDAQ:RSLSNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.1669
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1651/ 40
- Ask / Lots0.1700/ 46
- Open / Previous Close0.0000 / 0.1669
- Day Range---
- 52 Week Range
- Volume65,865
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RSLS |
|---|---|---|
| 09:43 ET | 100 | 0.171 |
| 09:52 ET | 3000 | 0.175 |
| 09:56 ET | 350 | 0.1652 |
| 10:08 ET | 249 | 0.173 |
| 10:10 ET | 1336 | 0.175 |
| 10:32 ET | 3142 | 0.1733 |
| 10:33 ET | 1790 | 0.1651 |
| 10:51 ET | 322 | 0.1734 |
| 11:13 ET | 1163 | 0.173 |
| 11:15 ET | 10628 | 0.1655 |
| 11:29 ET | 1020 | 0.1653 |
| 12:00 ET | 2100 | 0.1732 |
| 12:07 ET | 2000 | 0.1732 |
| 12:18 ET | 3100 | 0.1732 |
| 12:23 ET | 22133 | 0.1722 |
| 12:38 ET | 125 | 0.166201 |
| 12:50 ET | 2500 | 0.1732 |
| 12:52 ET | 1200 | 0.1732 |
| 12:54 ET | 150 | 0.1732 |
| 01:01 ET | 175 | 0.1672 |
| 01:06 ET | 9120 | 0.16975 |
| 02:22 ET | 955 | 0.166 |
| 02:38 ET | 5358 | 0.1715 |
| 02:44 ET | 1000 | 0.1715 |
| 02:45 ET | 15491 | 0.1715 |
| 02:47 ET | 8300 | 0.1732 |
| 03:57 ET | 1100 | 0.1732 |
| 03:59 ET | 1180 | 0.1669 |
Apr 1, 2024
ReShape Lifesciences(R) Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update, from 4:05PM ET on Monday Apr 01, 2024 by Dow Jones
4:05PM ET on Monday Apr 01, 2024 by Dow JonesPress Release: ReShape Lifesciences(R) Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update, from 4:05PM ET on Monday Apr 01, 2024 by Dow Jones
4:05PM ET on Monday Apr 01, 2024 by Dow Jones
Mar 28, 2024
ReShape Lifesciences(R) Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System, from 8:31AM ET on Thursday Mar 28, 2024 by Dow Jones
8:31AM ET on Thursday Mar 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
ReShape Lifesciences Inc | 3.9M | 0.0x | --- |
Nuwellis Inc | 2.3M | 0.0x | --- |
Arypsa Inc | 30.0 | 0.0x | --- |
Avinger Inc | 6.4M | -0.1x | --- |
Medite Cancer Diagnostics Inc | 8.7K | 0.0x | --- |
Biotricity Inc | 13.6M | -0.8x | --- |
Company Information
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Contact Information
- Headquarters
- 1001 CALLE AMANECERSAN CLEMENTE, CA, United States 92673
- Phone
- 949-429-6680
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board
- Dan Gladney
- President, Chief Executive Officer, Director
- Paul Hickey
- Chief Financial Officer
- Thomas Stankovich
- Lead Independent Director
- Gary Blackford
- Independent Director
- Lori Mcdougal
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.9M |
|---|---|
Revenue (TTM) | $8.7M |
Shares Outstanding | 23.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.32 |
EPS | $-3.77 |
Book Value | $0.28 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -177.25% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
